Research map: Dedifferentiation in endometrial cancer is associated with HLA ‐I silencing that may be restored by IFN ‐γ

Back to the article

Papers in this map

  1. Integrated genomic characterization of endometrial carcinoma · Douglas A. Levine · 2013 · 5971 citations · Cited by this paper
  2. Endoplasmic reticulum stress and the unfolded protein response in lung diseases: molecular pathways and therapeutic interventions · 2026 · Related
  3. Elements of cancer immunity and the cancer–immune set point · Daniel S. Chen · 2017 · 5536 citations · Cited by this paper
  4. Crohn's lymphoid aggregates with endothelial clusters colocalise with submucosal fibrosis in fibrostenosing Crohn's disease · 2026 · Related
  5. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies · Jérôme Galon · 2019 · 3583 citations · Cited by this paper
  6. Xenium‐based spatial transcriptomic analyses uncover prognosis‐associated heterogeneity in the tumor microenvironment ( TME ) of angioimmunoblastic T‐cell lymphoma ( AITL ) · 2026 · Related
  7. Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer · Scott N. Gettinger · 2017 · 792 citations · Cited by this paper
  8. Targeting fibrosis in the treatment of lower urinary tract dysfunction · 2026 · Related
  9. Clinical Use of Interferon‐γ · Catriona H. T. Miller · 2009 · 305 citations · Cited by this paper
  10. Testican‐1‐ MMP axis in tumour extracellular matrix ( ECM ) remodelling: interaction dynamics analysis and an in silico perspective · 2026 · Related
  11. Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment · Huizhong Xiong · 2019 · 204 citations · Cited by this paper
  12. FTO ‐mediated m6A modification of protein disulfide‐isomerase activates VEGFA – VEGFR2 to suppress programmed cell death in osteosarcoma · 2026 · Related
  13. Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial · Shihong Zhang · 2019 · 166 citations · Cited by this paper
  14. Immune dysregulation in the prostates of C57BL / 6 Aire −/− mice mirrors that seen in human benign prostatic hyperplasia · 2026 · Related
  15. Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas · Anthony Nicholas Karnezis · 2016 · 157 citations · Cited by this paper
  16. Human induced pluripotent stem cell‐derived chimeric antigen receptor‐macrophages eradicate IL ‐ 13Rα2 ‐positive solid tumors · 2026 · Related
  17. Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas · Mackenzie L. Coatham · 2016 · 122 citations · Cited by this paper
  18. Genetic analysis of primary lung interdigitating dendritic cell sarcomas · 2026 · Related
  19. Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function · Amy J. Petty · 2021 · 114 citations · Cited by this paper
  20. Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of ‘‐mabs’? · 2026 · Related
  21. SWI / SNF ‐deficiency defines highly aggressive undifferentiated endometrial carcinoma · Basile Tessier‐Cloutier · 2020 · 72 citations · Cited by this paper
  22. Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles · Beryl L. Manning‐Geist · 2022 · 72 citations · Cited by this paper
  23. Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel · Dario de Biase · 2020 · 71 citations · Cited by this paper
  24. Loss of switch/sucrose non‐fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas · Basile Tessier‐Cloutier · 2020 · 66 citations · Cited by this paper
  25. Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I · Valentina Ferrari · 2023 · 56 citations · Cited by this paper
  26. Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors · Ananthan Sadagopan · 2021 · 48 citations · Cited by this paper
  27. Clinico-pathological significance of TCGA classification and SWI/SNF proteins expression in undifferentiated/dedifferentiated endometrial carcinoma: A possible prognostic risk stratification · Angela Santoro · 2021 · 42 citations · Cited by this paper
  28. Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies) · Ruriko Ono · 2019 · 34 citations · Cited by this paper
  29. A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors · Matthew R. Zibelman · 2023 · 31 citations · Cited by this paper
  30. Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer · Dimitrios K. Korentzelos · 2022 · 25 citations · Cited by this paper
  31. Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria · Vanessa Daza-Cajigal · 2022 · 20 citations · Cited by this paper
  32. Genomic Determinants of De Novo Resistance to Immune Checkpoint Blockade in Mismatch Repair–Deficient Endometrial Cancer · D. Gulhan · 2020 · 17 citations · Cited by this paper
  33. MMR deficient undifferentiated/dedifferentiated endometrial carcinomas showing significant programmed death ligand-1 expression (sp 142) with potential therapeutic implications · Sean M. Hacking · 2019 · 16 citations · Cited by this paper
  34. Challenges of Using IFNγ in Clinical Settings · Snahlata Singh · 2023 · 12 citations · Cited by this paper
  35. Spatial Cancer-Immune Phenotypes Predict Shorter Recurrence-Free Survival in the No Specific Molecular Profile Molecular Subtype of Endometrial Carcinoma · Dario de Biase · 2024 · 12 citations · Cited by this paper
  36. Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma · Nelson K.Y. Wong · 2023 · 7 citations · Cited by this paper
  37. Assessment of IFNγ responsiveness in patient-derived xenografts · Jordan J. Cardenas · 2019 · 4 citations · Cited by this paper
  38. Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype · Marco Grillini · 2025 · 3 citations · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)